CRISPR enabled multiplexed genome engineering
US9982278B2 · kind B2 · utility
37Cited by
6References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2017 |
| Grant date | May 29, 2018 |
| Priority date | — |
| Expiry date | Jun 22, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2330/31
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Described herein are methods and vectors for rational, multiplexed manipulation of chromosomes within open reading frames (e.g., in protein libraries) or any segment of a chromosome in a cell or population of cells, in which various CRISPR systems are used.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.